Neoplasms by Site Completed Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01472146ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerTreatment